• FDA nod for Albireo drug makes it the first for children with rare liver disorder

    1 month ago - By MedCity News

    The FDA has approved Bylvay, an Albireo Pharma drug that treats the severe itching experienced by patients with progressive familial intrahepatic cholestasis. Prior to this approval, the only treatment options for the rare liver disorder were surgical.
    Read more ...